Literature DB >> 29240302

Correlation between sinus and lung cultures in lung transplant patients with cystic fibrosis.

Kevin J Choi1, Tracy Z Cheng1, Adam L Honeybrook1, Alice L Gray2, Laurie D Snyder2,3, Scott M Palmer2,3, Ralph Abi Hachem1, David W Jang1.   

Abstract

BACKGROUND: Lung transplantation has revolutionized the treatment of end-stage pulmonary disease due to cystic fibrosis. However, infection of the transplanted lungs can lead to serious complications, including graft failure and death. Although many of these patients have concurrent sinusitis, it is unclear whether bacteria from the sinuses can infect the allograft.
METHODS: This is a single-institution retrospective study of all patients who underwent lung transplantation for cystic fibrosis from 2005 to 2015 at Duke University Hospital. Pre- and posttransplant nasal and pulmonary cultures obtained via nasal endoscopy and bronchoalveolar lavage (BAL), respectively, were analyzed.
RESULTS: A total of 141 patients underwent 144 lung transplants. Sinus cultures were available for 76 patients (12 pretransplant, 42 posttransplant, 22 both pre- and posttransplant). Pretransplant BAL cultures were available for 139 patients, and posttransplant BAL cultures were available for all patients. Pseudomonas aeruginosa (PsA) and methicillin-resistant Staphylococcus aureus (MRSA) were the most common organisms cultured. There was a significant correlation between pretransplant sinus and posttransplant BAL cultures for PsA (p = 0.003), MRSA (p = 0.013), and Burkholderia cepacia (p = 0.001).
CONCLUSION: There was a high correlation between pretransplant sinus cultures and posttransplant BAL cultures for PsA, MRSA, and Burkholderia sp. This suggests that the paranasal sinuses may act as a reservoir for allograft colonization in patients with cystic fibrosis. Further studies are needed to determine whether treatment of sinusitis affects allograft colonization and transplant outcomes.
© 2017 ARS-AAOA, LLC.

Entities:  

Keywords:  MRSA; cystic fibrosis; lung transplant; pseudomonas; rhinosinusitis; sinus culture; sinusitis

Mesh:

Year:  2017        PMID: 29240302      PMCID: PMC5842113          DOI: 10.1002/alr.22067

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  13 in total

1.  The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report--2014; focus theme: retransplantation.

Authors:  Roger D Yusen; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Anne I Dipchand; Fabienne Dobbels; Samuel B Goldfarb; Bronwyn J Levvey; Lars H Lund; Bruno Meiser; Josef Stehlik
Journal:  J Heart Lung Transplant       Date:  2014-08-14       Impact factor: 10.247

2.  Bacterial pattern in chronic sinusitis and cystic fibrosis.

Authors:  Jose M Godoy; Andres N Godoy; Gloria Ribalta; Isabel Largo
Journal:  Otolaryngol Head Neck Surg       Date:  2011-04-26       Impact factor: 3.497

3.  Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis.

Authors:  J G Mainz; L Naehrlich; M Schien; M Käding; I Schiller; S Mayr; G Schneider; B Wiedemann; L Wiehlmann; N Cramer; W Pfister; B C Kahl; J F Beck; B Tümmler
Journal:  Thorax       Date:  2009-03-11       Impact factor: 9.139

4.  P. aeruginosa in the paranasal sinuses and transplanted lungs have similar adaptive mutations as isolates from chronically infected CF lungs.

Authors:  Oana Ciofu; Helle Krogh Johansen; Kasper Aanaes; Tina Wassermann; Morten Alhede; Christian von Buchwald; Niels Høiby
Journal:  J Cyst Fibros       Date:  2013-03-09       Impact factor: 5.482

5.  Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome.

Authors:  Phil Botha; Lynda Archer; Rachel L Anderson; Jim Lordan; John H Dark; Paul A Corris; Kate Gould; Andrew J Fisher
Journal:  Transplantation       Date:  2008-03-15       Impact factor: 4.939

6.  Staphylococcus aureus infections in the early period after lung transplantation: epidemiology, risk factors, and outcomes.

Authors:  Ryan K Shields; Cornelius J Clancy; Lucio R Minces; Eun J Kwak; Fernanda P Silveira; Rima C Abdel Massih; Yoshiya Toyoda; Christian Bermudez; Jay K Bhama; Norihisa Shigemura; Joseph M Pilewski; Maria Crespo; M Hong Nguyen
Journal:  J Heart Lung Transplant       Date:  2012-09-15       Impact factor: 10.247

Review 7.  Cystic fibrosis: a review of epidemiology and pathobiology.

Authors:  Steven D Strausbaugh; Pamela B Davis
Journal:  Clin Chest Med       Date:  2007-06       Impact factor: 2.878

8.  Effects of sinus surgery on lung transplantation outcomes in cystic fibrosis.

Authors:  Man-Kit Leung; Leelanand Rachakonda; David Weill; Peter H Hwang
Journal:  Am J Rhinol       Date:  2008 Mar-Apr

9.  Sinus surgery in cystic fibrosis patients: comparison of sinus and lower airway cultures.

Authors:  Brianne Barnett Roby; John McNamara; Marsha Finkelstein; James Sidman
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2008-07-03       Impact factor: 1.675

10.  Pneumonia after lung transplantation in the RESITRA Cohort: a multicenter prospective study.

Authors:  M Aguilar-Guisado; J Givaldá; P Ussetti; A Ramos; P Morales; M Blanes; G Bou; J de la Torre-Cisneros; A Román; J M Borro; R Lama; J M Cisneros
Journal:  Am J Transplant       Date:  2007-08       Impact factor: 8.086

View more
  7 in total

1.  Secretory IgA-mediated immune response in saliva and early detection of Pseudomonas aeruginosa in the lower airways of pediatric cystic fibrosis patients.

Authors:  Renan Marrichi Mauch; Claudio Lucio Rossi; Marcos Tadeu Nolasco da Silva; Talita Bianchi Aiello; José Dirceu Ribeiro; Antônio Fernando Ribeiro; Niels Høiby; Carlos Emilio Levy
Journal:  Med Microbiol Immunol       Date:  2019-01-31       Impact factor: 3.402

Review 2.  Challenges in the use of highly effective modulator treatment for cystic fibrosis.

Authors:  Kathleen J Ramos; Joseph M Pilewski; Jennifer L Taylor-Cousar
Journal:  J Cyst Fibros       Date:  2021-01-30       Impact factor: 5.482

3.  Diversity of cystic fibrosis chronic rhinosinusitis microbiota correlates with different pathogen dominance.

Authors:  Sarah K Lucas; Erin Feddema; Holly C Boyer; Ryan C Hunter
Journal:  J Cyst Fibros       Date:  2021-04-27       Impact factor: 5.527

Review 4.  Chronic rhinosinusitis in patients with cystic fibrosis-Current management and new treatments.

Authors:  Brian Jake Johnson; Garret W Choby; Erin K O'Brien
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-06-13

5.  Achromobacter spp. in a Cohort of Non-Selected Pre- and Post-Lung Transplant Recipients.

Authors:  Cornelia Geisler Crone; Omid Rezahosseini; Hans Henrik Lawaetz Schultz; Tavs Qvist; Helle Krogh Johansen; Susanne Dam Nielsen; Michael Perch
Journal:  Pathogens       Date:  2022-01-28

6.  Bacterial Re-Colonization Occurs Early after Lung Transplantation in Cystic Fibrosis Patients.

Authors:  Anna Engell Holm; Hans Henrik Lawaetz Schultz; Helle Krogh Johansen; Tania Pressler; Thomas Kromann Lund; Martin Iversen; Michael Perch
Journal:  J Clin Med       Date:  2021-03-19       Impact factor: 4.241

7.  Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis.

Authors:  Takashi Hirama; Fumiko Tomiyama; Hirotsugu Notsuda; Tatsuaki Watanabe; Yui Watanabe; Hisashi Oishi; Yoshinori Okada
Journal:  BMC Pulm Med       Date:  2021-08-13       Impact factor: 3.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.